| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0096 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |